DeepLife is a French biotech company located in Paris and on a mission to cure disease at the cellular level through AI-driven digital twins of cells technology. They develop cutting-edge approaches that integrate high-resolution multi-omics data, generative AI, and systems biology to simulate and understand cellular behavior. Their platform identifies key molecular drivers of disease and proposes targeted interventions to reprogram diseased cells into a healthy state. DeepLife accelerates therapeutic discovery through drug repurposing, combination therapy, and cell-specific modeling unlocking new treatment options for complex and underserved conditions